Cargando…

364. Diagnosis of Amebic Liver Abscess by a Commercial Multiplex Stool Amplification Assay. A Potentially Useful Alternative in Limited-Resources Settings.

BACKGROUND: Amoebic liver abscess (ALA) is caused by the protozoan parasite Entamoeba histolytica. Clinical and radiological features of ALA often mimic those of pyogenic liver abscess (PLA). Currently, differential diagnosis between ALA and PLA relys on microscopic examination, anti-amoebic IgG ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Murillo, Jorge, Torres, Jaime, Baquero, Julio, Leal, Vanessa, Jimenez, Ana, Martinez, Elena, Garcia, Chloris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751991/
http://dx.doi.org/10.1093/ofid/ofac492.442
_version_ 1784850609049960448
author Murillo, Jorge
Torres, Jaime
Baquero, Julio
Leal, Vanessa
Jimenez, Ana
Martinez, Elena
Garcia, Chloris
author_facet Murillo, Jorge
Torres, Jaime
Baquero, Julio
Leal, Vanessa
Jimenez, Ana
Martinez, Elena
Garcia, Chloris
author_sort Murillo, Jorge
collection PubMed
description BACKGROUND: Amoebic liver abscess (ALA) is caused by the protozoan parasite Entamoeba histolytica. Clinical and radiological features of ALA often mimic those of pyogenic liver abscess (PLA). Currently, differential diagnosis between ALA and PLA relys on microscopic examination, anti-amoebic IgG serology, and culture of aspirate for pyogenic organisms. Therefore, there is a need for new, rapid and more accurate microbiological methods for diagnosing ALA. Unfortunately, with few exceptions, available reports involved the use of inhouse or laboratory-tailored polymerase chain reaction (PCR) assays. We herein report our recent experience with the successful use of a commercial multiplex, nested PCR assay designed for stool, in the diagnosis of two cases of ALA. METHODS: Two severely ill adult Latin American migrants presented with fever, malaise, non-bloody diarrhea, abdominal pain and leukocytosis. CT scans revealed single large hypodense, inflammatory, liver cystic lesions. RESULTS: Necrotic material obtained by needle aspiration under guidance and stool samples were processed by FilmArray Gastrointestinal Panel (BioFire Diagnostics, Salt Lake City), designed to detect 13 bacterial, 5 viral and 4 parasitic pathogens, both amplified only for E. hystolitica DNA. ELISA serology for amoeba was also positive. Bacterial cultures were sterile. Treatment with Metronidazole and paromomycin resulted in complete recovery. CONCLUSION: Analysis of liver abscess content using a commercially available, multiplex, nested PCR assay designed for stool, may represent a convenient alternative to currently available diagnostic methods, providing rapid results and allowing for immediate choosing of specific therapy targeting single pathogens on more rational basis. Since there are several commercially available multiplex PCR panels containing primers for E. histolytica, their use for evaluation of liver abscess samples has some theoretical advantages for the diagnosis of ALA, such as simplicity, ample availability, rapid processing time and capacity to exclude simultaneously several potential pathogens. Nevertheless, further testing is necessary to validate their use in liver abscess diagnosis and define their false positivity and negativity rates. DISCLOSURES: All Authors: No reported disclosures.
format Online
Article
Text
id pubmed-9751991
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97519912022-12-16 364. Diagnosis of Amebic Liver Abscess by a Commercial Multiplex Stool Amplification Assay. A Potentially Useful Alternative in Limited-Resources Settings. Murillo, Jorge Torres, Jaime Baquero, Julio Leal, Vanessa Jimenez, Ana Martinez, Elena Garcia, Chloris Open Forum Infect Dis Abstracts BACKGROUND: Amoebic liver abscess (ALA) is caused by the protozoan parasite Entamoeba histolytica. Clinical and radiological features of ALA often mimic those of pyogenic liver abscess (PLA). Currently, differential diagnosis between ALA and PLA relys on microscopic examination, anti-amoebic IgG serology, and culture of aspirate for pyogenic organisms. Therefore, there is a need for new, rapid and more accurate microbiological methods for diagnosing ALA. Unfortunately, with few exceptions, available reports involved the use of inhouse or laboratory-tailored polymerase chain reaction (PCR) assays. We herein report our recent experience with the successful use of a commercial multiplex, nested PCR assay designed for stool, in the diagnosis of two cases of ALA. METHODS: Two severely ill adult Latin American migrants presented with fever, malaise, non-bloody diarrhea, abdominal pain and leukocytosis. CT scans revealed single large hypodense, inflammatory, liver cystic lesions. RESULTS: Necrotic material obtained by needle aspiration under guidance and stool samples were processed by FilmArray Gastrointestinal Panel (BioFire Diagnostics, Salt Lake City), designed to detect 13 bacterial, 5 viral and 4 parasitic pathogens, both amplified only for E. hystolitica DNA. ELISA serology for amoeba was also positive. Bacterial cultures were sterile. Treatment with Metronidazole and paromomycin resulted in complete recovery. CONCLUSION: Analysis of liver abscess content using a commercially available, multiplex, nested PCR assay designed for stool, may represent a convenient alternative to currently available diagnostic methods, providing rapid results and allowing for immediate choosing of specific therapy targeting single pathogens on more rational basis. Since there are several commercially available multiplex PCR panels containing primers for E. histolytica, their use for evaluation of liver abscess samples has some theoretical advantages for the diagnosis of ALA, such as simplicity, ample availability, rapid processing time and capacity to exclude simultaneously several potential pathogens. Nevertheless, further testing is necessary to validate their use in liver abscess diagnosis and define their false positivity and negativity rates. DISCLOSURES: All Authors: No reported disclosures. Oxford University Press 2022-12-15 /pmc/articles/PMC9751991/ http://dx.doi.org/10.1093/ofid/ofac492.442 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Murillo, Jorge
Torres, Jaime
Baquero, Julio
Leal, Vanessa
Jimenez, Ana
Martinez, Elena
Garcia, Chloris
364. Diagnosis of Amebic Liver Abscess by a Commercial Multiplex Stool Amplification Assay. A Potentially Useful Alternative in Limited-Resources Settings.
title 364. Diagnosis of Amebic Liver Abscess by a Commercial Multiplex Stool Amplification Assay. A Potentially Useful Alternative in Limited-Resources Settings.
title_full 364. Diagnosis of Amebic Liver Abscess by a Commercial Multiplex Stool Amplification Assay. A Potentially Useful Alternative in Limited-Resources Settings.
title_fullStr 364. Diagnosis of Amebic Liver Abscess by a Commercial Multiplex Stool Amplification Assay. A Potentially Useful Alternative in Limited-Resources Settings.
title_full_unstemmed 364. Diagnosis of Amebic Liver Abscess by a Commercial Multiplex Stool Amplification Assay. A Potentially Useful Alternative in Limited-Resources Settings.
title_short 364. Diagnosis of Amebic Liver Abscess by a Commercial Multiplex Stool Amplification Assay. A Potentially Useful Alternative in Limited-Resources Settings.
title_sort 364. diagnosis of amebic liver abscess by a commercial multiplex stool amplification assay. a potentially useful alternative in limited-resources settings.
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751991/
http://dx.doi.org/10.1093/ofid/ofac492.442
work_keys_str_mv AT murillojorge 364diagnosisofamebicliverabscessbyacommercialmultiplexstoolamplificationassayapotentiallyusefulalternativeinlimitedresourcessettings
AT torresjaime 364diagnosisofamebicliverabscessbyacommercialmultiplexstoolamplificationassayapotentiallyusefulalternativeinlimitedresourcessettings
AT baquerojulio 364diagnosisofamebicliverabscessbyacommercialmultiplexstoolamplificationassayapotentiallyusefulalternativeinlimitedresourcessettings
AT lealvanessa 364diagnosisofamebicliverabscessbyacommercialmultiplexstoolamplificationassayapotentiallyusefulalternativeinlimitedresourcessettings
AT jimenezana 364diagnosisofamebicliverabscessbyacommercialmultiplexstoolamplificationassayapotentiallyusefulalternativeinlimitedresourcessettings
AT martinezelena 364diagnosisofamebicliverabscessbyacommercialmultiplexstoolamplificationassayapotentiallyusefulalternativeinlimitedresourcessettings
AT garciachloris 364diagnosisofamebicliverabscessbyacommercialmultiplexstoolamplificationassayapotentiallyusefulalternativeinlimitedresourcessettings